3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Thoracic Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Neoplasms by Site
1
Neoplasms
1
Lung Neoplasms
1
Lung Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Bronchial Neoplasms
1
Interventions
Carboplatin
5
Pemetrexed
4
pembrolizumab
3
Paclitaxel
3
Gemcitabine
2
Erlotinib Hydrochloride
2
Cisplatin
2
pralsetinib
1
patritumab
1
napabucasin
1
camrelizumab
1
Vinorelbine
1
TNFSF10 protein, human
1
Radiotherapy, Intensity-Modulated
1
Nivolumab
1
Injections
1
Gefitinib
1
Docetaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Thoracic Neoplasms
×
patritumab
×
Clear all
NCT02134015
2018-01-23
HER3-Lung
Daiichi Sankyo
Phase 3
Terminated
145 enrolled
20 charts